Ian T. Forbes
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Pharmacological Receptor Mechanisms and Effects, Chemical synthesis and alkaloids
Most-Cited Works
- → SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist(1997)523 cited
- → A Novel, Potent, and Selective 5-HT7Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)(2000)249 cited
- → In vitroandin vivoprofile of SB 206553, a potent 5‐HT2C/5‐HT2Breceptor antagonist with anxiolytic‐like properties(1996)240 cited
- → Characterization of a CNS penetrant, selective M1muscarinic receptor agonist, 77‐LH‐28‐1(2008)131 cited
- → SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats(2003)119 cited
- → Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719(1998)115 cited
- → Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist(2005)107 cited
- Urinary erythrocyte morphology in the diagnosis of glomerular hematuria.(1983)
- → (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7Receptor Antagonist(1998)102 cited
- → SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety(2001)100 cited